The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of empirically eliminating 5-fluorouracil (5-FU) bolus and leucovorin (LV) in patients with metastatic colorectal cancer (mCRC) receiving first-line treatment with mFOLFOX6.
 
Alexa Basilio
No Relationships to Disclose
 
Anand Shah
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Coherus Biosciences; Ipsen; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Coherus Biosciences; Ipsen; Taiho Pharmaceutical
 
Katelyn Sommerer
No Relationships to Disclose
 
Sarah Chehab
No Relationships to Disclose
 
Salvatore Michael Bottiglieri
Honoraria - Array BioPharma; Eisai; Merck
Consulting or Advisory Role - Array BioPharma; Eisai
Speakers' Bureau - Merck
 
Iman Imanirad
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Signatera